(Q40950978)

25 September 2017

1 reference

title

The emerging role of valproate in bipolar disorder and other psychiatric disorders (English)

1 reference

25 September 2017

1 reference

Guay DR

1

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

15

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

631-647

1 reference

Valproate in the treatment of acute mania. A placebo-controlled study

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

GABA and circadian timekeeping: implications for manic-depression and sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Manic psychosis following rapid withdrawal from baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Alterations in Motor Activity, Sleep, and Biochemistry in a Cycling Manic-Depressive Patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Dysphoric mania. Clinical and biological correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Sodium Valproate Increases Potassium Conductance in Aplysia Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Effect of selective bilateral destruction of the substantia nigra on antiepileptic drug actions in kindled rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Contested boundaries of bipolar disorder and the limits of categorical diagnosis in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Acute behaviour disturbances

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Rapid cycling patients: conceptual and etiological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Treatment approaches for acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

A double-blind comparison of valproate and lithium in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Verapamil and valproic acid treatment of prolonged mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Effect of sodium valproate on tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Effects of a GABA-Mimetic Drug (Sodium Valproate) on Visually Evoked Potentials in Chronic Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

The effect of sodium valproate on tardive dyskinesia--revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Valproate treatment of older psychotic patients with organic mental syndromes and behavioral dyscontrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Valproate treatment of panic disorder and lactate-induced panic attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Treatment of Panic Disorder and Benzodiazepine Withdrawal With Valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Probable interaction of sodium divalproex with benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Autism: electroencephalogram abnormalities and clinical improvement with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Sodium valproate in the treatment of behavioral disturbance in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

The effects of sodium valproate on disturbed behavior in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Head injury, bipolar disorder, and response to valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Major depression in patients with agoraphobia and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Panic disorder: clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

New findings in the treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Drug treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Course and outcome in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

The diagnosis and treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

The effects of valproate in brain monoamines of juvenile rats after stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Side effects of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Psychological effects of sodium valproate and carbamazepine in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Valproate as psychotropic agent. Interactions and adverse cerebral reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

Drug interactions with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02874.X

10.1002/J.1875-9114.1995.TB02874.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference